Clinical Trial

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

Name: JAB-2485 Activity in Adult Patients With Advanced Solid Tumors — clinical trial record (NCT05490472)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This study is to evaluate the safety and tolerability of JAB-2485 monotherapy in adult participants with advanced solid tumors.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2022-08-04; most recent amendment 2026-01-07.

Status change: Not Yet Recruiting → Recruiting 2023-01-04

Trial Details

NCT Number	NCT05490472
Lead Sponsor	Jacobio Pharmaceuticals Co., Ltd.
Conditions	Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC, ARID1A Gene Mutation, Small Cell Lung Cancer, SCLC
Enrollment	102 participants
Start Date	2022-12-20
Primary Completion	2026-08 (estimated)
Study Completion	2027-08 (estimated)
Updated on ClinicalTrials.gov	2026-01-09